Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cost of Revenue | Cost of Revenue Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 132K | 26.4% | $ 500K |
3/31/2025 | $ 0 | 0% | $ 0 |
12/31/2024 | $ 0 | 0% | $ 0 |
6/30/2024 | $ -494.75K | -45.39% | $ 1.09M |
12/31/2023 | $ 2.57M | 25.74% | $ 10M |
6/30/2023 | $ 2.34M | 26.25% | $ 8.91M |
12/31/2022 | $ -1.17M | 0% | $ 0 |
6/30/2022 | $ -726.25K | 0% | $ 0 |
12/31/2021 | $ 22.39M | 49.11% | $ 45.58M |
6/30/2021 | $ 22.67M | 49.74% | $ 45.58M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
COGS / Revenues
(=) COGS %
COGS % for MEREO BIOPHARMA GROUP PLC is calculated as follows: COGS [ $ 0 ] / Revenues [ $ 0 ]
(=) COGS % [ 0% ]
Minimum
Jun 30, 2024
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.8K |
---|---|
min | -50.26% |
max | 172.25% |
average | 46.88% |
median | 50.52% |
std | 31.58% |